GSK commences tender offer to acquire Human Genome Sciences for US $13.00 per share in cash Full Text
GlaxoSmithKline,

GlaxoSmithKline plc announced that it has commenced its previously announced tender offer to acquire all of the outstanding shares of Human Genome Sciences for US$13.00 per share in cash. GSK's offer represents a premium of 81 percent to HGS's closing share price of US$7.17 on 18th April, the last trading day before HGS publicly disclosed GSK's private offer.

Please login or register to follow this author.
Are you sure you want to Unfollow this Author?
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pharma News

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pharma News Articles

1 FDA approves Afrezza to treat diabetes Full Text FDA Press Announcements, June 30, 2014    Free full text

2 Using price-volume agreements to manage pharmaceutical leakage and off-label promotion The European Journal of Health Economics, September 26, 2014    Clinical Article

3 AbbVies HUMIRA (adalimumab) receives U.S. FDA approval for the treatment of pediatric patients with moderately to severely active Crohn's disease AbbVie, September 26, 2014

4 FDA releases REMS report Full Text BioPharm International, September 26, 2014    Free full text

5 Medigene to present at Baader Investment Conference Munich Full Text MediGene, September 26, 2014    Free full text

6 Announcement under Irish takeover rules relevant securities in issue - September 24, 2014 Covidien, September 26, 2014

7 Optum labs adds four partners for big data research Healthcare Informatics, September 26, 2014

8 Study observed association between JANSSEN CONNECT injection centers and increased adherence to healthcare provider-ordered janssen long-acting treatment for people with schizophrenia Full Text Janssen, September 26, 2014    Free full text

9 IBA and Philips leverage proton therapy to improve cancer treatment Imaging Economics, September 26, 2014

10 Eppendorf - Production of stem cells in single-use vessels Full Text BioPharm International, September 26, 2014    Free full text

11 Daiichi Sankyo and Charleston Laboratories announce collaboration to develop and commercialize novel, fixed-dose combination hydrocodone products for pain and opioid-induced nausea and vomiting (OINV) in the US Full Text Daiichi Sankyo, September 26, 2014    Free full text

12 GlaxoSmithKline plc appoints Sir Philip Hampton to the Board of Directors Full Text GlaxoSmithKline, September 26, 2014    Free full text

13 FDA receives paragraph IV notice letter for KUVAN (sapropterin dihydrochloride) tablets Full Text BioMarin, September 26, 2014    Free full text

14 Measures to quantify the abuse of prescription opioids: a review of data sources and metrics Pharmacoepidemiology and Drug Safety, September 26, 2014    Review Article

15 Biotech investment veteran Robert F. Johnston joins Hurel investor group B3C newswire, September 26, 2014

16 US FDA accepts Otsuka and Lundbeck's filing for review of brexpiprazole for the treatment of schizophrenia and as adjunctive therapy for the treatment of major depression Full Text Lundbeck, September 26, 2014    Free full text

17 Pandemic vaccine facility dedicated in Texas Full Text BioPharm International, September 26, 2014    Free full text

18 Bristol-Myers Squibb to build state-of-the-art campus in Lawrenceville, N.J. Full Text Bristol Myers-Squibb, September 26, 2014    Free full text

19 USP supports WHO biologics naming proposal Full Text BioPharm International, September 26, 2014    Free full text

20 Biogen Idec to report third quarter 2014 financial results on october 22, 2014 Biogen Idec, September 26, 2014

Indexed Journals in Pharma News: U.S.Pharmacist, FDA Drug Alerts, Pharmiwebmore

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register
Upcoming Clinical Trials UPCOMING Clinical Trials

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close